Indication for a Pneumocystis Prophylaxis Therapy in Patients with Vascular Anomalies Treated with PIK3/AKT/mTOR Pathway Inhibitors: Experts' Opinion and Systematic Review from the Literature

Navarro, M; Allemang-Trivalle, A; Leducq, S; Jonville-Bera, AP; Maurier, A; Zejli, T; Edee, AE; Harchaoui, E; Giraudeau, B; Maruani, A

Maruani, A (通讯作者)，CHRU Tours, Dept Dermatol, Unit Pediat Dermatol, Tours, France.;Maruani, A (通讯作者)，Reference Ctr Genodermatoses & Rare Skin Dis MAGEC, Tours, France.

DERMATOLOGY, 2023; 239 (6): 942

Abstract

Background: Vascular anomalies (VAs) are increasingly being treated with PI3K/AKT/mTOR pathway inhibitors. These drugs have immunosuppressive properti......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索